FTLF at a glance
FITLIFE BRANDS, INC. (FTLF, SEC CIK 1374328) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 16, 2026, an 8-K current report on November 17, 2026 and Form 4 insider filings as recently as September 2, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), FITLIFE BRANDS, INC. (FTLF) reported revenue of $81.5 million (up 26.4% from FY2024) and net income of $6.3 million. Diluted EPS was $0.63.
- As of September 30, 2026, 8 institutional investment managers tracked by SignalX reported holding FITLIFE BRANDS, INC. (FTLF) shares worth $2.0 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by Pappas Shannon K. on August 19, 2026 of 1,000 shares at $10.25 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $81.5M
- +26.4% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 8 funds
- $2.0M · −2 vs prior quarter
- Latest 8-K
- Nov 17, 2026
- Item 2.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Management Discussion & Analysis
- Q3 revenue $25,620, up 9% from $23,485, driven by a full quarter of Irwin operations
- Gross margin 37.7% vs 37.2% YoY, with net income $1,571 vs $921
- Best performer: Irwin revenue $13,016, up 91%; worst: Legacy FitLife revenue $12,604, down 24%
- Cash $689, operating cash flow $4,445, term loan repayments $4,571, Credit Line repayments $800
- Outlook: liquidity sufficient for next twelve months, restructuring expected to reduce annual expenses by approximately $1,200
Risk Factors
- No material changes to risk factors from the December 31, 2025 Form 10-K
- Carried-forward business risk: identified risks could negatively impact operations and financial condition
- Carried-forward uncertainty: future prospects remain subject to disclosed risk factors and uncertainties
AI summary of the FTLF 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Press release announces FitLife Brands’ financial results for quarter ended September 30, 2026
- Exhibit 99.1 contains the detailed quarterly financial results and management commentary
Item EX-99.1: Item EX-99.1
- Q3 revenue $25.6M, up 9%, driven by Irwin, while Legacy FitLife revenue fell 24%
- Net income $1.6M, up 71%, but adjusted EBITDA declined 13% to $3.3M
Item 7.01: Regulation FD Disclosure
- New corporate presentation adopted September 9, 2026 for business purposes
- Exhibit 99.1 contains management’s current investor and business messaging
Item 5.07: Submission of Matters to a Vote of Security Holders
- All five director nominees elected through 2027 annual meeting, preserving board continuity
- Dayton Judd received 6,473,347 votes for and 7,871 withheld, the strongest director support
Item 2.02: Results of Operations and Financial Condition
- Press release announces FitLife Brands’ financial results for the quarter ended June 30, 2026
- Investors should review Exhibit 99.1 for revenue, earnings, margins and management commentary
Item EX-99.1: Item EX-99.1
- Q2 revenue $26.5M, up 65%, but growth heavily acquisition-driven by Irwin’s $14.1M contribution
- Legacy FitLife revenue fell 23% to $12.4M, with wholesale down 31% and online down 19%, primarily involving GNC and MRC
AI summaries of FTLF 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for FTLF
Don't miss the next FTLF filing
- Alerts as it files. A push when FTLF files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut FTLF, by share count.
- Ask anything. An AI agent that reads every FTLF filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| York Jakob | A | Aug 28, 2026 | 4,000 | - |
| Pappas Shannon K. | Buy | Aug 19, 2026 | 1,000 | $10.25 |
| Hansen Ryan P. | A | May 15, 2026 | 28,500 | - |
| Hansen Ryan P. | A | May 15, 2026 | 46,500 | - |
| Hansen Ryan P. | A | May 15, 2026 | 50,000 | - |
| Lingenbrink Matthew | Buy | Apr 10, 2026 | 3,000 | $9.76 |
| Dawson Grant Robert | Buy | Apr 10, 2026 | 3,000 | $9.98 |
| Yakatan Seth | Buy | Jan 15, 2026 | 164 | $15.36 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $64.5M | $81.5M |
| Gross Profit | - | $28.1M | $31.5M |
| Operating Income | - | $13.1M | $10.1M |
| Net Income | - | $9.0M | $6.3M |
| Gross Margin | - | 43.6% | 38.6% |
| Op. Margin | - | 20.3% | 12.4% |
| Net Margin | - | 13.9% | 7.8% |
| Balance Sheet | |||
| Total Assets | $55.3M | $58.5M | $106.3M |
| Equity | - | $36.1M | $43.6M |
| ROE | - | 24.9% | 14.5% |
| Per Share | |||
| EPS | $1.08 | $0.91 | $0.63 |
| Cash Flow | |||
| Operating CF | - | $9.6M | $7.4M |
| CapEx | - | $10K | $42K |
Source: XBRL data in FITLIFE BRANDS, INC. (FTLF)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate FTLF share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 8 | $2.0M |
| Q2 2026 | 10 | $2.9M |
| Q1 2026 | 12 | $6.4M |
| Q4 2025 | 13 | $8.2M |
| Q3 2025 | 11 | $9.7M |
| Q2 2025 | 12 | $6.1M |
| Q1 2025 | 8 | $2.2M |
- BlackRock−21.8K (-62%)
- Millennium Management−4.5K (-19%)
- Morgan Stanley−699 (-69%)
- Citigroup+3.5K
- Wells Fargo & Co+102
Source: 13F-HR filings on SEC EDGAR (aggregated from 74 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
FTLF filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Nov 17, 2026 | - | Analysis | - |
| 10-Q | Nov 16, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Sep 9, 2026 | - | Analysis | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Aug 21, 2026 | - | - | - |
| 10-Q | Aug 13, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 8-K | May 22, 2026 | - | Analysis | |
| 4 | May 19, 2026 | - | - | |
| 10-Q | May 14, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 14, 2026 | - | Analysis | |
| 4 | Apr 20, 2026 | - | - | - |
| 4 | Apr 14, 2026 | - | - | - |
| 4 | Apr 14, 2026 | - | - | - |
| 8-K | Apr 7, 2026 | - | Analysis | - |
| 8-K | Apr 1, 2026 | - | - | - |
| 10-K | Mar 31, 2026 | Dec 31, 2025 | - | |
| 8-K | Dec 10, 2025 | - | - | |
| 10-Q | Nov 13, 2025 | Sep 30, 2025 | Analysis | |
| 10-Q | Aug 14, 2025 | Jun 30, 2025 | - | |
| 10-Q | May 15, 2025 | Mar 31, 2025 | - | |
| 10-K | Mar 27, 2025 | Dec 31, 2024 | Analysis | |
| SC 13G | Jan 17, 2025 | - | - | |
| 10-Q | Nov 14, 2024 | Sep 30, 2024 | - | |
| 10-Q | Aug 14, 2024 | Jun 30, 2024 | - |
Related Health Care companies
- BTMD · biote Corp.Medicinal Chemicals & Botanical Products
- DFTX · Definium Therapeutics, Inc.Medicinal Chemicals & Botanical Products
- MDWD · MediWound Ltd.Medicinal Chemicals & Botanical Products
- NAGE · Niagen Bioscience, Inc.Medicinal Chemicals & Botanical Products
- USNA · USANA HEALTH SCIENCES INCMedicinal Chemicals & Botanical Products
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
FTLF SEC filings: frequently asked questions
Which institutions hold FTLF stock?
As of September 30, 2026, the largest FITLIFE BRANDS, INC. (FTLF) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($1.4 million), Millennium Management ($176,000), State Street Corp ($152,000), BlackRock ($126,000), Dimensional Fund Advisors ($95,000). 13F-HR reports are filed up to 45 days after each quarter ends.
What was FTLF's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), FITLIFE BRANDS, INC. (FTLF) reported revenue of $81.5 million (up 26.4% from FY2024) and net income of $6.3 million. Diluted EPS was $0.63. The figures come from the XBRL data in the 10-K.
What did FTLF report in its latest 8-K?
FITLIFE BRANDS, INC. (FTLF) filed an 8-K on November 17, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Press release announces FitLife Brands’ financial results for quarter ended September 30, 2026.
What are the latest FTLF SEC filings?
FITLIFE BRANDS, INC. (FTLF) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 16, 2026, an 8-K current report on November 17, 2026 and a Form 4 insider filing on September 2, 2026.
What is FTLF's SEC CIK number?
FITLIFE BRANDS, INC. (FTLF)'s SEC Central Index Key (CIK) is 1374328. EDGAR lists every FTLF filing under that number.
Ask anything about FTLF
The research agent reads FTLF's filings, financials, insider trades and 13F holders, then answers with sources.